Simplex Trading’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-9,510
| Closed | -$743K | – | 9311 |
|
|
2025
Q2 | $743K | Buy |
+9,510
| New | +$709K | ﹤0.01% | 3099 |
|
|
2024
Q2 | – | Sell |
-64,004
| Closed | -$5.67M | – | 9047 |
|
|
2024
Q1 | $6.12M | Buy |
64,004
+36,021
| +129% | +$3.03M | ﹤0.01% | 1456 |
|
|
2023
Q4 | $2.13M | Buy |
+27,983
| New | +$1.95M | ﹤0.01% | 2301 |
|
|
2023
Q2 | – | Sell |
-100
| Closed | -$8.69K | – | 9224 |
|
|
2023
Q1 | $8K | Buy |
+100
| New | +$7.86K | ﹤0.01% | 7713 |
|
|
2022
Q1 | – | Sell |
-6,972
| Closed | -$782K | – | 10655 |
|
|
2021
Q4 | $903K | Sell |
6,972
-24,620
| -78% | -$2.87M | ﹤0.01% | 3002 |
|
|
2021
Q3 | $3.31M | Buy |
31,592
+15,066
| +91% | +$1.72M | ﹤0.01% | 1572 |
|
|
2021
Q2 | $1.71M | Sell |
16,526
-601
| -4% | -$56.6K | ﹤0.01% | 2371 |
|
|
2021
Q1 | $1.43M | Sell |
17,127
-9,438
| -36% | -$798K | ﹤0.01% | 2001 |
|
|
2020
Q4 | $0 | Buy |
+26,565
| New | +$2.2M | ﹤0.01% | 8530 |
|
|
2020
Q2 | – | Sell |
-30,471
| Closed | -$2.17M | – | 7787 |
|
|
2020
Q1 | $1.92M | Buy |
30,471
+26,946
| +764% | +$1.94M | ﹤0.01% | 1309 |
|
|
2019
Q4 | $274K | Buy |
+3,525
| New | +$275K | ﹤0.01% | 3405 |
|
|
2019
Q3 | – | Sell |
-4,278
| Closed | -$301K | – | 7403 |
|
|
2019
Q2 | $263K | Buy |
+4,278
| New | +$259K | ﹤0.01% | 3201 |
|
|
2018
Q4 | – | Sell |
-61,047
| Closed | -$3.09M | – | 7206 |
|
|
2018
Q3 | $3.54M | Sell |
61,047
-27,765
| -31% | -$1.36M | 0.01% | 827 |
|
|
2018
Q2 | $4.31M | Buy |
+88,812
| New | +$4.15M | 0.02% | 635 |
|
|
2018
Q1 | – | Sell |
-8,790
| Closed | -$382K | – | 6323 |
|
|
2017
Q4 | $330K | Buy |
+8,790
| New | +$323K | 0.01% | 941 |
|
|
2017
Q2 | – | Sell |
-18,198
| Closed | -$664K | – | 6281 |
|
|
2017
Q1 | $570K | Buy |
18,198
+13,686
| +303% | +$428K | 0.02% | 615 |
|
|
2016
Q4 | $140K | Buy |
4,512
+3,753
| +494% | +$122K | 0.01% | 1287 |
|
|
2016
Q3 | $30K | Sell |
759
-7,158
| -90% | -$270K | ﹤0.01% | 2564 |
|
|
2016
Q2 | $263K | Buy |
7,917
+3,987
| +101% | +$136K | 0.02% | 837 |
|
|
2016
Q1 | $115K | Sell |
3,930
-37,905
| -91% | -$1.05M | 0.01% | 1239 |
|
|
2015
Q4 | $1.1M | Buy |
41,835
+31,983
| +325% | +$831K | 0.09% | 194 |
|
|
2015
Q3 | $233K | Buy |
9,852
+1,986
| +25% | +$47.9K | 0.02% | 821 |
|
|
2015
Q2 | $186K | Sell |
7,866
-14,874
| -65% | -$336K | 0.02% | 830 |
|
|
2015
Q1 | $539K | Sell |
22,740
-19,656
| -46% | -$441K | 0.06% | 308 |
|
|
2014
Q4 | $900K | Buy |
+42,396
| New | +$852K | 0.11% | 157 |
|
Other funds holding EW
VCM
VPM
Simplex Trading's EW Position: Q3 2025 in Review
Simplex Trading sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 9,510 shares — an estimated $743K sold.
Simplex Trading first reported a position in EW in Q4 2014 and held it in 25 quarters. The position peaked at $6.12M in Q1 2024. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.
- Simplex Trading reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 9,510 Edwards Lifesciences shares in Q3 2025, an estimated $743K.
- Simplex Trading first reported a position in Edwards Lifesciences in Q4 2014 and held it in 25 quarters.
- Simplex Trading's Edwards Lifesciences position peaked at $6.12M in Q1 2024.
- 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.